Fidelity Investments’s Cullinan Oncology CGEM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$103K	Buy	7,232 +2,634	+57%	+$33.9K	﹤0.01%	3783
2025 Q4	$47.6K	Buy	4,598 +3,630	+375%	+$32.7K	﹤0.01%	4141
2025 Q3	$5.74K	Sell	968 -2,844	-75%	-$20.8K	﹤0.01%	4754
2025 Q2	$28.7K	Buy	3,812 +1,253	+49%	+$10.1K	﹤0.01%	4142
2025 Q1	$19.4K	Sell	2,559 -40,233	-94%	-$386K	﹤0.01%	4232
2024 Q4	$521K	Buy	42,792 +22,432	+110%	+$322K	﹤0.01%	2911
2024 Q3	$341K	Buy	20,360 +19,681	+2,899%	+$349K	﹤0.01%	3004
2024 Q2	$11.8K	Buy	679 +153	+29%	+$3.26K	﹤0.01%	4272
2024 Q1	$8.96K	Buy	526 +84	+19%	+$1.3K	﹤0.01%	4318
2023 Q4	$4.5K	Sell	442 -1,132	-72%	-$10K	﹤0.01%	4482
2023 Q3	$14.2K	Sell	1,574 -53,348	-97%	-$556K	﹤0.01%	3972
2023 Q2	$591K	Buy	54,922 +650	+1%	+$6.9K	﹤0.01%	2605
2023 Q1	$555K	Sell	54,272 -34,114	-39%	-$376K	﹤0.01%	2657
2022 Q4	$932K	Sell	88,386 -41,148	-32%	-$500K	﹤0.01%	2559
2022 Q3	$1.66M	Sell	129,534 -84,532	-39%	-$1.14M	﹤0.01%	2477
2022 Q2	$2.74M	Sell	214,066 -1,415,114	-87%	-$16M	﹤0.01%	2408
2022 Q1	$17.1M	Buy	1,629,180 +689,140	+73%	+$9.31M	﹤0.01%	1855
2021 Q4	$14.5M	Sell	940,040 -1,560,172	-62%	-$31.1M	﹤0.01%	1968
2021 Q3	$56.4M	Buy	2,500,212 +522,305	+26%	+$14M	﹤0.01%	1361
2021 Q2	$50.9M	Buy	1,977,907 +757,733	+62%	+$23.3M	﹤0.01%	1420
2021 Q1	$50.8M	Buy	+1,220,174	New	+$49.5M	﹤0.01%	1393

Other funds holding CGEM